Chevy Chase Trust’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-27,758
| Closed | -$6.82M | – | 659 |
|
|
2022
Q3 | $6.82M | Buy |
27,758
+243
| +0.9% | +$59.7K | 0.03% | 444 |
|
|
2022
Q2 | $6.81M | Buy |
27,515
+149
| +0.5% | +$36.9K | 0.03% | 455 |
|
|
2022
Q1 | $9.07M | Buy |
27,366
+81
| +0.3% | +$26.8K | 0.03% | 435 |
|
|
2021
Q4 | $9.8M | Sell |
27,285
-579
| -2% | -$208K | 0.03% | 423 |
|
|
2021
Q3 | $9.07M | Sell |
27,864
-999
| -3% | -$325K | 0.03% | 427 |
|
|
2021
Q2 | $9.01M | Sell |
28,863
-1,493
| -5% | -$466K | 0.03% | 437 |
|
|
2021
Q1 | $9.68M | Sell |
30,356
-2,411
| -7% | -$768K | 0.03% | 424 |
|
|
2020
Q4 | $10.6M | Sell |
32,767
-635
| -2% | -$206K | 0.04% | 395 |
|
|
2020
Q3 | $9.26M | Sell |
33,402
-2,782
| -8% | -$771K | 0.04% | 385 |
|
|
2020
Q2 | $8.74M | Sell |
36,184
-1,276
| -3% | -$308K | 0.04% | 398 |
|
|
2020
Q1 | $5.44M | Sell |
37,460
-272
| -0.7% | -$39.5K | 0.03% | 438 |
|
|
2019
Q4 | $6.44M | Buy |
37,732
+761
| +2% | +$130K | 0.02% | 487 |
|
|
2019
Q3 | $6.58M | Sell |
36,971
-729
| -2% | -$130K | 0.03% | 471 |
|
|
2019
Q2 | $9.82M | Buy |
37,700
+72
| +0.2% | +$18.8K | 0.04% | 405 |
|
|
2019
Q1 | $10.4M | Buy |
37,628
+538
| +1% | +$149K | 0.04% | 397 |
|
|
2018
Q4 | $12.1M | Buy |
37,090
+222
| +0.6% | +$72.2K | 0.06% | 318 |
|
|
2018
Q3 | $16.6M | Buy |
36,868
+1,296
| +4% | +$583K | 0.07% | 292 |
|
|
2018
Q2 | $14.6M | Buy |
+35,572
| New | +$14.6M | 0.06% | 320 |
|